Locust Walk Acquisition Corp.

Status: Deal Closed
U=S+W/3 W=S@11.5
Target: eFFECTOR Therapeutics; Closing Date: Aug 25, 2021
IPO Proceeds, $M $175.00M
IPO Date Jan 8, 2021
CEO Chris Ehrlich
Left Lead Cantor Fitzgerald
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Healthcare in the United States and Europe

IPO Geography Global
Target Company eFFECTOR Therapeutics
Deal Announced May 27, 2021
Deal Size, $M $419.00M
Deal Geography US/Canada
Deal Sector Healthcare
SEC Filings www.sec.gov
Closing Date Aug 25, 2021
Formerly LWAC EFTR EFTRW


Sign up for Free Trial

No credit card required

Sign in for more data on Locust Walk Acquisition Corp.:

  • 8 directors & officers
  • 14 filings and events
  • 1 underwriters
  • 7 deal advisors
  • 2 legal advisors
  • 153 shareholders (from 13F filings)